The reported incidence of positive tests for humoral antibody in cryptococcal infections has varied from 45 to 80% (2, 12, 16) . Although studies have shown no apparent relation between antibody titer and severity or type of infection (9, 12) , Diamond and Bennett (5) (2) .
Positive tests for antibody appear to be inversely related to the quantity of antigen in the patient. For example, 22 of 29 patients with cryptococcal meningoencephalitis and a negative India ink smear of cerebrospinal fluid had detectable antibody in their serum, whereas only 4 of 40 patients with positive India ink smears had positive tests for antibody (2) . Conversely, the incidence of positive antibody tests in patients increases when the patients exhibit solitary lung lesions, no central nervous system involvement, or early central nervous system involvement (9, 10, 19) . These observations of cryptococcosis in human beings as well as several studies of immune response to cryptococcal polysaccharide in animals (17) (15) .
Animals. Eight-to ten-week-old female white Swiss mice weighing 20 to 26 g were used. Food and water were supplied to the animals ad libitum.
Soluble polysaccharide. The method used to purify cryptococcal polysaccharide was a modification of that used by Evans and Theriault (7) and has been described in detail elsewhere (15 (20) . All tests for significance were done at the P = 0.05 level.
RESULTS
Induction of immunological unresponsiveness. The experimental procedure used to demonstrate immune unresponsiveness to cryptococcal polysaccharide was similar to the protocol used by Felton et al. (8) with pneumococcal polysaccharide. Groups of mice were given intraperitoneal injections (0.2 ml) of 25 to 800 ,ug of polysaccharide in saline. A control group was injected intraperitoneally with saline. All mice were challenged 10 days later with a subcutaneous injection (0.2 ml) of 20 ,Lg of cryptococcal polysaccharide emulsified in Freund incomplete adjuvant. All mice were bled 17 days after challenge, and their serum was titrated by passive hemagglutination. Induction of immune paralysis by the initial injection of polysaccharide was indicated by an antibody titer lower than that of the control. The results are shown in Fig. 1 Fig. 2 to levels of polysaccharide in serum of mice. Groups of 40 mice each were injected intraperitoneally (0.2 ml) with 50, 100, 200, or 400 ,ug of cryptococcal polysaccharide in saline. Four or five animals from each group were bled at 1-h, 12-h, 1-day, 3-day, 7-day, and 14-day intervals, and levels of polysaccharide in serum were assayed by complement fixation. The results (Fig. 3) Effects of long-term and low-dose exposure to cryptococcal polysaccharide. Cryptococcosis often follows a chronic course, and the patient may be exposed to cryptococcal polysaccharide for long periods of time. Presumably, the dose of polysaccharide to which the patient is exposed may vary considerably. An experiment was done to determine the effects of prolonged exposure to polysaccharide upon the total amount of polysaccharide necessary to induce immune unresponsiveness. Three groups of mice were divided into 8 lots of 10 animals each. Each lot of mice was given a total of 0.1, 0.4, 1.6, 6.4, 25, 100, or 400 ,ug of polysaccharide in saline or an injection of saline alone. The first group was given a single intraperitoneal injection of the specified amount of polysaccharide. The second group of mice received the specified amount of polysaccharide in a total of four intraperitoneal injections given every other day; i.e., an animal that was to receive 400,g of polysaccharide was given injections of 100 ug on alternate days for four injections. Injections of polysaccharide for the third group of mice were divided into 16 doses given every other day. Control animals were given injections of saline. All mice were challenged 10 days after the last dose of polysaccharide with a subcutaneous injection (0.2 ml) of 20,ug of crytococcal polysaccharide emulsified in Freund incomplete adjuvant. Blood was drawn 17 days later, and serum was titrated by passive hemagglutination.
The results (Fig. 4) showed that all animals given a single injection of 0.1, 0.4, and 1.6 ,ug of polysaccharide responded to the challenge immunization at levels considerably above the control group. Animals given 6.4 and 25 ,ug responded with titers similar to those of the con- trol. Increasing degrees of immune unresponsiveness were noted in mice treated with 100 and 400 <g of polysaccharide.
Unlike the case in animals given a single injection, dividing polysaccharide doses of 0.1, 0.4, 1.6, and 6.4 ,ug into four injections produced a response to the challenge immunization that did not differ significantly (P = 0.05) from the response of the control group. The mean titer of animals given 25 ytg of polysaccharide may have been slightly below the control response, whereas animals given 100 and 400 ,ug of polysaccharide were almost totally unresponsive.
Animals given polysaccharide in 16 injections responded to the challenge almost identically to animals given 4 injections. Total polysaccharide doses of 0.1, 0.4, 1.6, 6.4, and 25 ,ug did not significantly (P = 0.05) affect the production of humoral antibody. Animals given a total of 100 and 400 ,g responded quite poorly.
The data in Figure 4 suggested that cryptococcal polysaccharide might be sequestered in some manner until an amount of polysaccharide sufficient for induction of paralysis is accumulated. Accordingly, an experimnent was done to consider this possibility. Mice were injected intraperitoneally with 100 fig of polysaccharide, and they were sacrificed at varying time intervals over a 14-week period. Several organs were removed, and frozen sections were examined by immunfluorescence to determine the distribution of antigen in the body. A faint amount of nonspecific background fluorescence was observed when tissues from untreated mice were examined or when normal rabbit serum was substituted for anti-cryptococcal serum. Immunofluorescent examination of tissue from treated tissue 1 day and 8 days after injection of antigen showed a weak granular staining of the connec- tive tissue in many organs including lung, liver, spleen, thymus, lymph node, and heart. Localization of antigen in these tissues diminished rapidly, and cryptococcal polysaccharide could not be found in these tissues 4 weeks after injection of polysaccharide. There appeared to be no localization of polysaccharide either on or in the macrophages of any organ studied. Localization of polysaccharide in the kidney was in marked contrast to any other tissue studied. Accumulation of the polysaccharide in the tubular epithelial cells was noted 24 h after injection of polysaccharide. The polysaccharide appeared as fine, intensely stained granules that appeared to be located within the tubular cells. The granules enlarged, reaching a maximum approximately 4 weeks after injection of polysaccharide (Fig. 5) . After 4 weeks, the granules gradually subsided in both number and staining intensity; however, weak staining was still apparent in the tubular epithelial cells at the termination of the experiment 14 weeks after injection of polysaccharide.
At no time did there appear to be any localization of polysaccharide in the glomerulus.
DISCUSSION
The ability of cryptococcal polysaccharide to induce immunological unresponsiveness was clearly demonstrated by Murphy and Cozad (18) . Their results showed this unresponsiveness to be the result of a suppression of antibody synthesis rather than a neutralization of antibody by excess antigen. The present study confirmed the induction of immunological unresponsiveness by cryptococcal polysaccharide. Our use of circulating antibody as an indicator of immunological responsiveness rather than measurement of antibody production at a cellular level, however, makes it impossible to confirm the mechanism described by Murphy and Cozad (18) .
Escape from immunological unresponsiveness in the form of reversion to production of antibody to cryptococcal polysaccharide without further antigenic stimulation was not seen during a 12-week observation period. This may explain the infrequency of reports of seroconversion from negative to positive antibody tests~~~~~~~~~~~~~~~~'~~~~~~~~~~~~~~~2 FIG. 5 show that induction of unresponsiveness in the host appears to be dependent upon the total amount of polysaccharide to which the host is exposed, with duration of exposure being of little consequence.
Studies on the effects of multiple injections of antigen on induction of unresponsiveness suggested that cryptococcal polysaccharide might be sequestered in some manner until an amount of polysaccharide sufficient for induction of paralysis is accumulated. Immunofluorescent studies provided direct evidence for long-term deposition of cryptococcal polysaccharide in the tubular epithelial cells of the kidney. Significant long-term deposition of cryptococcal polysaccharide was not noted in other organs that were studied. The pattern of tissue localization of cryptococcal polysaccharide appears markedly different from the distribution of type II and III pneumococcal polysaccharide. Kaplan et al. (11) reported that the most constant and striking concentrations ofpneumococcal polysaccharides were found in cells of the reticuloendothelial system, the capillary endothelium, and fibroblasts throughout the body. We observed no localization of cryptococcal polysaccharide in macrophages. These in vivo results also confirm earlier in vitro observations that cryptococcal polysaccharide does not bind to cultured macrophages (14) . The distribution of cryptococcal INFECT. IMMUN. polysaccharide in human cryptococcosis is not known and remains an area for further study.
